Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report

Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashii, Masafumi, Ebina, Kosuke, Kitaguchi, Kazuma, Yoshikawa, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284126/
https://www.ncbi.nlm.nih.gov/pubmed/32548215
http://dx.doi.org/10.1016/j.bonr.2020.100288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284126/
https://www.ncbi.nlm.nih.gov/pubmed/32548215
http://dx.doi.org/10.1016/j.bonr.2020.100288

Ejemplares similares